nanoRETE

About:

nanoRETE develops field-operable, nanoparticle-based biosensors for the real-time detection of pathogens and toxins.

Top Investors: InvestMichigan, Michigan Accelerator Fund I

Description:

nanoRETE, Inc. develops field-operable nanoparticle-based biosensors for the rapid diagnosis of infections disease agents. The company focuses on pathogen and toxin detection within the food safety and supply markets. Its handheld point-of-care biosensors are used in public health, homeland defense, food supply chain, and economic infrastructures. nanoRETE, Inc. was founded in 2011 and is based in Lansing, Michigan.

Total Funding Amount:

$1.65M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lansing, Michigan, United States

Founded Date:

2011-01-01

Contact Email:

ksheline(AT)chartercapitalpartners.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2015-05-23

IPO Status:

Private

Industries: